These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3401188)
1. Clomipramine in obsessional disorders: a cautionary tale. Morstyn R Aust N Z J Psychiatry; 1988 Jun; 22(2):190-4. PubMed ID: 3401188 [TBL] [Abstract][Full Text] [Related]
2. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923 [TBL] [Abstract][Full Text] [Related]
4. Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions. Capstick N Scott Med J; 1975; 20(1 SUPPL):45-8. PubMed ID: 1154013 [TBL] [Abstract][Full Text] [Related]
5. Clomipramine in phobic and obsessional states: preliminary report. Silva FR; Wijewickrama HS N Z Med J; 1976 Jul; 84(567):4-6. PubMed ID: 1067503 [TBL] [Abstract][Full Text] [Related]
6. Clomipramine (Anafranil) in depressive patients with obsessive neurosis. Singh AN; Sexena B; Gent M J Int Med Res; 1977; 5 Suppl 5():25-32. PubMed ID: 598603 [TBL] [Abstract][Full Text] [Related]
7. The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder. Warneke LB Can J Psychiatry; 1984 Mar; 29(2):135-41. PubMed ID: 6722705 [TBL] [Abstract][Full Text] [Related]
9. An uncontrolled trial of clomipramine (Anafranil) in the treatment of phobic and obsessional states in general practice. Gringras M J Int Med Res; 1977; 5 Suppl 5():111-5. PubMed ID: 598599 [TBL] [Abstract][Full Text] [Related]
10. An investigation into the use of anafranil in phobic and obsessional disorders. Waxman D Scott Med J; 1975; 20(1 SUPPL):61-6. PubMed ID: 1154017 [TBL] [Abstract][Full Text] [Related]
11. Chlorimipramine therapy for obsessive-compulsive neurosis. Ananth J; Solyom L; Bryntwick S; Krishnappa U Am J Psychiatry; 1979 May; 136(5):700-1. PubMed ID: 434251 [TBL] [Abstract][Full Text] [Related]
12. Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine. Zerjav-Lacombe S; Dewan V Ann Pharmacother; 2001 Feb; 35(2):180-2. PubMed ID: 11215836 [TBL] [Abstract][Full Text] [Related]
13. A predictive study of obsessive-compulsive disorder response to clomipramine. Alarcon RD; Libb JW; Spitler D J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737 [TBL] [Abstract][Full Text] [Related]
14. The role of intravenous clomipramine in the treatment of obsessional and phobic disorders. Marshall WK; Micev V Scott Med J; 1975; 20(1 SUPPL):49-53. PubMed ID: 1154014 [TBL] [Abstract][Full Text] [Related]
15. Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders. Amin MM; Ban TA; Pecknold JC; Klingner A J Int Med Res; 1977; 5 Suppl 5():33-7. PubMed ID: 340305 [TBL] [Abstract][Full Text] [Related]
16. Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescent. Hermesh H; Aizenberg D; Weizman A; Lapidot M; Munitz H Drug Intell Clin Pharm; 1987 Nov; 21(11):877-9. PubMed ID: 3678059 [TBL] [Abstract][Full Text] [Related]
17. Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil). Ananth J J Int Med Res; 1977; 5 Suppl 5():38-41. PubMed ID: 598604 [TBL] [Abstract][Full Text] [Related]
19. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine. Alarcon RD; Johnson BR; Lucas JP J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience in the treatment of obsessional states (1). Capstick N J Int Med Res; 1977; 5 Suppl 5():71-80. PubMed ID: 598607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]